Neuroimaging – Products

Study confirms ALZmetrixTM whole blood test can detect people at high risk of developing full Alzheimer’s Disease.

Oncodesign Services announces the execution of a Preclinical License and Supply Agreement with ImaginAb Inc. for the use of their investigational CD8 ImmunoPET™ (89Zr crefmirlimab berdoxam) technology.

Cleveland Diagnostics, Inc., a commercial-stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers, has opened a new, state-of-the-art facility.

Personalis, Inc., Cancer Research UK’s Cancer Research Horizons, University College London and the Francis Crick Institute have announced a collaboration to deploy a personalized liquid biopsy-based research assay, for the TRACERx study.

Bruker Corporation has announced the signing of the definitive agreement to purchase 100% of the shares of Neurescence Inc., an innovative provider of ultralight fiber-bundle MultiscopesTM for simultaneous multi-region, optical functional neuroimaging.

Bruker Corporation has announced the acquisition of Inscopix, Inc., a neuroscience pioneer and marketer of miniaturized microscopes, known as miniscopes, for freely moving animal brain imaging.

Fujifilm Europe will unveil its latest products at ECR 2022.

The Wellcome-funded initiative run by Health Data Research UK to promote interest in, and broaden access to, careers in health data research has launched its 2022 program.

Maxwell™ Preclinical MRI Magnets do not require liquid helium, facilitating siting.

BrainGlobe, an open-source, community-driven platform for computational neuroanatomy, has been awarded two grants from the Chan Zuckerberg Initiative (CZI).